(Q51225150)

1 April 2018

title

The case test-negative design for studies of the effectiveness of influenza vaccine. (English)

1 reference

1 April 2018

1 reference

1 reference

1 reference

4

1 reference

1 April 2018

author name string

Ivo M Foppa

series ordinal

1

1 reference

1 April 2018

Michael Haber

series ordinal

2

1 reference

1 April 2018

Jill M Ferdinands

series ordinal

3

1 reference

1 April 2018

language of work or name

English

0 references

publication date

23 April 2013

1 reference

1 April 2018

published in

Vaccine

1 reference

1 April 2018

volume

31

1 reference

1 April 2018

issue

30

1 reference

1 April 2018

page(s)

3104-3109

1 reference

1 April 2018

Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Effectiveness of pentavalent rotavirus vaccine against severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Complications of seasonal and pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Virus interference and estimates of influenza vaccine effectiveness from test-negative studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

Measures of the effects of vaccination in a randomly mixing population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.026

10.1016/J.VACCINE.2013.04.026

7 January 2021

Identifiers

DOI

1 reference

1 April 2018

1 reference

1 April 2018